Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NMT Medical Inc.

www.nmtmedical.com

Latest From Philips Respironics

New-Gen Devices Offer Sleep Apnea Patients Alternative CPAP Routes

With half or more of all diagnosed obstructive sleep apnea patients who need continuous positive airway pressure machines unwilling or unable to use these devices, there’s a large unmet need for an alternative treatment. Startups are rising to the challenge with neuromodulation platforms, a mouthguard-like suction device, a nasal device with microblowers, and a vibrating device that nudges patients to turn on their sides.

Respiratory StartUps and SMEs

Medtronic Targets Airway Management, Respiratory Monitoring For Rapid Growth

Medtronic is moving quickly to increase its market share in airway management and respiratory monitoring and is expanding its product portfolio to help hospitals reduce the incidence of respiratory compromise and preventable adverse events. The company recently acquired Aircraft Medical and its video laryngoscopy business, launched its own laryngeal mask product and identified a wide range of potential applications for its fast-growing capnography product line.

Medical Device Innovation

ESC 2015: ‘Shocking’ Outcomes Of Sleep Apnea-Heart Failure Trial Spell Gloom For ResMed

Results from the SERVE-HF trial, presented at the recent European Society of Cardiology meeting and published in the NEJM, showed systolic heart failure patients with central sleep apnea treated with adaptive servo-ventilation actually had worse mortality outcomes than the control group. These results "shocked " both the respiratory and cardiology community and spell gloom for ResMed's sleep apnea therapy.

Medical Device Clinical Trials

Warning Letter Close-Outs – March 2015

Four FDA close-out letters were released in March.

Medical Device Regulation
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Therapeutic Areas
  • Cardiovascular
  • Alias(es)
  • Nitinol Medical Technologies Inc.
  • Ownership
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • NMT Medical Inc.
  • Senior Management
  • Contact Info
  • NMT Medical Inc.
    Phone: (617) 737-0930
    27 Wormwood St.
    Boston, MA 02210-1625
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register